Sleep Apnea Syndromes
Welcome,         Profile    Billing    Logout  
 18 Companies   33 Products   33 Products   37 Mechanisms of Action   1 Trial   994 News 


«12...891011121314151617181920
  • ||||||||||  New P2/3 trial:  The ATLAST Long-Term Study (clinicaltrials.gov) -  Nov 20, 2011   
    P2/3,  N=39, Completed, 
  • ||||||||||  Enrollment change:  Face of Sleepiness (clinicaltrials.gov) -  Oct 18, 2011   
    P=N/A,  N=30, Active, not recruiting, 
    No longer recruiting --> Completed N=20 --> 30
  • ||||||||||  Enrollment closed:  Face of Sleepiness (clinicaltrials.gov) -  Oct 18, 2011   
    P=N/A,  N=30, Active, not recruiting, 
    N=1400 --> 1685 Recruiting --> Active, not recruiting
  • ||||||||||  acetazolamide / Generic mfg.
    Trial termination:  Buspirone as a Potential Treatment for Recurrent Central Apnea (clinicaltrials.gov) -  Sep 25, 2011   
    P3,  N=28, Terminated, 
    Recruiting --> Completed Recruiting --> Terminated; Patient recruitment and Funding inadequate to finish trial